A multinational drugmaker is paying 45 states including South Dakota $105 million to settle complaints that the company unlawfully marketed three drugs.
South Dakota Attorney General Marty Jackley says South Dakota's share of the settlement is nearly $1.2 million.
The settlement resolves allegations that London-based Glaxo illegally marketed Advair, Paxil and Wellbutrin for purposes that had not been approved by the Food and Drug Administration. Once the FDA approves a drug as safe and effective, a manufacturer cannot market or promote that drug for an unapproved use, a practice called off-label marketing.
The asthma treatment Advair is Glaxo's best-selling product. Paxil and Wellbutrin are antidepressant drugs.
Most Popular Today
Allegiant Air Pilot Pleads With Tower To Make Emergency Landing
- 2.Retail & Restaurants
Lick The Spoon Closes East Side Location
Famous Wine Maker Planning Sioux Falls Development
- 4.Retail & Restaurants
Filly Flair Set To Open Sioux Falls Store On Saturday
- 5.Retail & Restaurants
Downtown Business Expanding
US Official: Debris In Photo Belongs To Boeing 777
South Dakota Cities Are Tops For Worktirement
- 8.Meetings & Events
Construction Delays Force Cancellation Of Concert
New Publisher Named For Capital Journal Newspaper In Pierre
Thursday Morning Business Brief